Review
Published on 26 Sep 2023
Matrix metalloproteinases and tissue inhibitors in multiple myeloma: promote or inhibit?
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1127407
- 4,752 views
- 8 citations
Type at least 3 characters
1,825 articles
Original Research
Published on 25 Sep 2023
NOTCH1-mutated chronic lymphocytic leukemia displays high endoplasmic reticulum stress response with druggable potential
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1218989
- 3,296 views
- 8 citations
Review
Published on 22 Sep 2023
Updates in pathobiological aspects of anaplastic large cell lymphoma
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1241532
- 4,531 views
- 4 citations
Original Research
Published on 20 Sep 2023
The prognostic significance of circulating plasma cells in newly diagnosed multiple myeloma patients
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1266868
- 1,888 views
- 2 citations
Original Research
Published on 19 Sep 2023
Multi-omics investigation of the resistance mechanisms of pomalidomide in multiple myeloma
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1264422
- 3,852 views
Original Research
Published on 18 Sep 2023
Evaluation of factors leading to poor outcomes for pediatric acute lymphoblastic leukemia in Mexico: a multi-institutional report of 2,116 patients
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1255555
- 4,274 views
- 3 citations
Review
Published on 14 Sep 2023
Contribution of the Epstein-Barr virus to the oncogenesis of mature T-cell lymphoproliferative neoplasms
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1240359
- 6,026 views
- 2 citations
Brief Research Report
Published on 13 Sep 2023
Impact of circulating lymphoma cells at diagnosis on outcomes in patients with Waldenstrom macroglobulinemia
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1264387
- 1,999 views
- 1 citation
Case Report
Published on 13 Sep 2023
Case Report: Mycosis fungoides as an exclusive manifestation of common variable immunodeficiency in a family with a NFKB2 gene mutation
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1248964
- 2,028 views
- 3 citations
Original Research
Published on 12 Sep 2023
Fertility preservation and monitoring in adult patients diagnosed with lymphoma: consensus-based practical recommendations by the Fondazione Italiana Linfomi & SocietĂ Italiana della Riproduzione Umana
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1252433
- 4,094 views
- 4 citations
Original Research
Published on 11 Sep 2023
Overcoming the therapeutic limitations of EZH2 inhibitors in Burkitt’s lymphoma: a comprehensive study on the combined effects of MS1943 and Ibrutinib
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1252658
- 2,666 views
- 4 citations
Mini Review
Published on 11 Sep 2023
Hematopoietic cell transplantation and gene therapy for Diamond-Blackfan anemia: state of the art and science
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1236038
- 5,724 views
- 6 citations
Case Report
Published on 08 Sep 2023
Invasive splenic mucormycosis due to Rhizopus microsporus during chemotherapy for acute monocytic leukemia: a case report and literature review
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1237807
- 1,837 views
- 2 citations
Original Research
Published on 08 Sep 2023
Extracorporeal light-chain elimination in myeloma with simple medium cutoff membrane hemodialysis: a retrospective cohort study
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1193504
- 2,823 views
Original Research
Published on 08 Sep 2023
Clinicopathological analysis of diffuse large B-cell lymphoma using molecular biomarkers: a retrospective analysis from 7 Hungarian centers
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1224733
- 1,883 views
Case Report
Published on 07 Sep 2023
Case Report: ASXL1, RUNX1, and IDH1 mutation in tyrosine kinase-independent resistant chronic myeloid leukemia progressing to chronic myelomonocytic leukemia-like accelerated phase
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1217153
- 1,768 views
- 1 citation